Me& secures US$2.5m capital raise
Australian start-up Me& has been advised on its US$2.5 million seed capital raising in a bid to fund further research and development.
Firm: Herbert Smith Freehills (Me&)
To continue reading the rest of this article, please log in.
Create free account to get unlimited news articles and more!
Deal: Herbert Smith Freehills has advised Me& on its US$2.5 million Series Seed capital raise, which was led by Horizons and Main Sequence Ventures.
Value: US$2.5 million
Area: Venture capital
Key players: The HSF team was led by co-head of venture capital Australia Claire Thompson and solicitor Vincent Greco Schwartz, supported by partner Clayton James.
Deal significance: Founded by Dr Luis Malaver-Ortega and Esha Saxena, Me& is an Australian company that is developing and commercialising human milk products using proprietary technology. An example of the company’s product is a human-milk fortifier used for preterm and vulnerable babies. The new capital will be employed to fund research and development, as well as the growth of the company.
Commenting on the deal, HSF said it “was a pleasure working with Esha and Luis at such an exciting time in the development of their company. We love advising founders in the early stages of growth and we are excited to see how they will deploy these investments to propel their business into the next phase.”